Aprea Therapeutics, Inc. (APRE)
0.8386
-0.02
(-2.50%)
USD |
NASDAQ |
Aug 28, 16:00
0.8361
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Operations (Quarterly) : -3.206M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.206M |
| March 31, 2026 | -2.757M |
| December 31, 2025 | -3.067M |
| September 30, 2025 | -3.267M |
| June 30, 2025 | -3.478M |
| March 31, 2025 | -3.631M |
| December 31, 2024 | -3.172M |
| September 30, 2024 | -2.627M |
| June 30, 2024 | -3.539M |
| March 31, 2024 | -3.936M |
| December 31, 2023 | -3.863M |
| September 30, 2023 | -2.089M |
| June 30, 2023 | -3.187M |
| March 31, 2023 | -2.979M |
| Date | Value |
|---|---|
| December 31, 2022 | -4.038M |
| September 30, 2022 | -5.535M |
| June 30, 2022 | -8.532M |
| March 31, 2022 | -5.495M |
| December 31, 2021 | -9.542M |
| September 30, 2021 | -7.700M |
| June 30, 2021 | -7.741M |
| March 31, 2021 | -11.52M |
| December 31, 2020 | -14.34M |
| September 30, 2020 | -13.16M |
| June 30, 2020 | -9.642M |
| March 31, 2020 | -7.542M |
| December 31, 2019 | -10.43M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Zymeworks, Inc. | -31.59M |
| Rhythm Pharmaceuticals, Inc. | -9.152M |
| Onconetix, Inc. | -1.918M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0152M |
| Cash from Financing (Quarterly) | -2.334M |
| Free Cash Flow | -12.31M |
| Free Cash Flow Per Share (Quarterly) | -0.0602 |
| Free Cash Flow to Equity (Quarterly) | -3.221M |
| Free Cash Flow to Firm (Quarterly) | -3.221M |
| Free Cash Flow Yield | -71.42% |